SPDR S&P Biotech (XBI) - Stock Price & Dividends

The SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that aims to replicate the performance of the S&P Biotechnology Select Industry Index. To achieve this, the fund uses a sampling strategy, which means it selects a representative sample of securities from the index to invest in.

The fund typically invests at least 80% of its total assets in the securities that make up the index. This index, in turn, represents the biotechnology segment of the broader S&P Total Market Index (S&P TMI), which tracks the US stock market.

By investing in the SPDR S&P Biotech ETF, you'll gain exposure to a diverse range of biotechnology companies, from small-cap to large-cap, that are driving innovation and advancements in the biotech industry. This can be a great way to tap into the growth potential of this exciting and rapidly evolving sector.

The fund is listed on the NYSE Arca exchange under the ticker symbol XBI, and you can find more information about it on the SPDR website at http://www.spdrs.com.

As a US-domiciled fund, the SPDR S&P Biotech ETF is subject to US regulations and is designed to provide investors with a convenient and cost-effective way to access the biotech sector.